Exploratory study for identifying EMT-associated genes as novel therapeutics for lung cancer
Project/Area Number |
23591145
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Respiratory organ internal medicine
|
Research Institution | Nagoya University |
Principal Investigator |
MITSUO Sato 名古屋大学, 医学部附属病院, 講師 (70467281)
|
Co-Investigator(Kenkyū-buntansha) |
MASASHI Kondo 名古屋大学, 大学院医学系研究科, 准教授 (00378077)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 肺癌 / マイクロRNA / 上皮間葉細胞転換 / EMT / 肺がん / 細胞周期 / アポトーシス / 国際情報交換 / 不死化正常気管支細胞 / p53 / KRAS / EGFR / p53 |
Research Abstract |
We evaluated the potential of miR-221 and miR222 as novel therapeutics for lung cancer. These microRNAs are shown to induce epithelial to mesenchymal transition (EMT) in normal mammary epithelial cells. Upon introduction of miR-221 or miR222, immortalized normal human bronchial epithelial cells underwent morphological changes, suggestive of EMT, in association with expression changes in EMT-associated genes. miR-221 and miR222 promoted growth in several lung cancer cell lines but suppressed in other cell lines. Cell cycle and apoptosis analyses revealed that growth suppressive effects by miR-221 and miR-221 occur through S-phase arrest and/or apoptosis. These data suggested the potential of miR-221 and miR222 as novel therapeutics for lung cancer.
|
Report
(4 results)
Research Products
(22 results)
-
[Journal Article] IMELESS is overexpressed in lung cancer and its expression correlates with poor patient survival.2013
Author(s)
Yoshida K, Sato M, Hase T, Elshazley M, Yamashita R, Usami N, Taniguchi T, Yokoi K, Nakamura S, Kondo M, Girard L, Minna JD, Hasegawa Y.
-
Journal Title
Cancer Sci.
Volume: 104
Issue: 2
Pages: 171-7
DOI
Related Report
Peer Reviewed
-
[Journal Article] Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations.2013
Author(s)
Sato M, Larsen JE, Lee W, Sun H, Shames DS, Dalvi MP, Ramirez RD, Tang H, DiMaio JM, Gao B, Xie Y, Wistuba II, Gazdar AF, Shay JW, Minna JD
-
Journal Title
Mol Cancer Res
Volume: 11
Issue: 6
Pages: 638-650
DOI
Related Report
Peer Reviewed
-
[Journal Article] NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM.2013
Author(s)
Osborne JK, Larsen JE, Shields MD, Gonzales JX, Shames DS, Sato M, Kulkarni A, Wistuba II, Girard L, Minna JD, Cobb MH
-
Journal Title
Proc Natl Acad Sci U S A.
Volume: 110
Issue: 16
Pages: 6524-9
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations.2013
Author(s)
Sato M, Larsen JE, Lee W, Sun H, Shames DS, Dalvi MP, Ramirez RD, Tang H, Dimaio JM, Gao B, Xie Y, Wistuba II, Gazdar AF, Shay JW, Minna JD
-
Journal Title
Mol Cancer Res
Volume: in press
Related Report
Peer Reviewed
-
[Journal Article] Transient but not stable ZEB1 knockdown dramatically inhibits growth of malignant pleural mesothelioma cells.2012
Author(s)
Horio M, Sato M, Takeyama Y, Elshazley M, Yamashita R, Hase T, Yoshida K, Usami N, Yokoi K, Sekido Y, Kondo M, Toyokuni S, Gazdar AF, Minna JD, Hasegawa Y
-
Journal Title
Ann Surg Oncol
Volume: 19 Supple3
Issue: S3
Pages: 634-645
DOI
Related Report
Peer Reviewed
-
[Journal Article] The circadian clock gene BMAL1 is a novel therapeutic target for malignant mesothelioma.2012
Author(s)
Elshazley M, Sato M, Hase T, Yamashita R, Yoshida K, Toyokuni S, Ishiguro F, Osada H, Sekido Y, Yokoi K, Usami N, Shames DS, Kondo M, Gazdar AF, Minna JD, Hasegawa Y
-
Journal Title
Int J Cancer
Volume: 131
Issue: 12
Pages: 2820-31
DOI
Related Report
Peer Reviewed
-
[Journal Article] Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.2012
Author(s)
Sunaga N, Kaira K, Imai H, Shimizu K, Nakano T, Shames DS, Girard L, Soh J, Sato M, Iwasaki Y, Ishizuka T, Gazdar AF, Minna JD, Mori M.
-
Journal Title
Oncogene
Volume: 印刷中
Issue: 34
Pages: 4034-4042
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Transient but Not Stable ZEB1 Knockdown Dramatically Inhibits Growth of Malignant Pleural Mesothelioma Cells.2012
Author(s)
Horio M, Sato M, Takeyama Y, Elshazley M, Yamashita R, Hase T, Yoshida K, Usami N, Yokoi K, Sekido Y, Kondo M, Toyokuni S, Gazdar AF, Minna JD, Hasegawa Y.
-
Journal Title
Ann Surg Oncol.
Volume: 印刷中
Related Report
Peer Reviewed
-
-
-
-
-
-
[Presentation] THE COMBINATION OF FIVE CHANGES (TELOMERASE, P16/RB BYPASS, P53 KNOCKDOWN, KRASV12, C-MYC) TOGETHERWITH SERUM-INDUCED EPITHELIAL MESENCHYMAL TRANSITION PROGRESSES NORMAL HUMAN BRONCHIAL EPITHELIAL CELLS TO FULL MALIGNANCY2012
Author(s)
Mitsuo Sato, Jill E. Larsen, Woochang Lee, David Shames, Ignacio I. Wistuba, Adi F. Gazdar3, Jerry W. Shay, John D. Minna, Masashi Kondo, Yoshinori Hasegawa
Organizer
第5回アジア太平洋肺癌会議
Place of Presentation
Hilton Fukuoka Sea Hawkホテル、福岡市
Year and Date
2012-11-28
Related Report
-
[Presentation] "THE COMBINATION OF FIVE CHANGES (TELOMERASE, P16/RB BYPASS, P53 KNOCKDOWN, KRASV12, C-MYC) TO- GETHER WITH SERUM-INDUCED EPITHELIAL MESENCHYMAL TRANSITION PROGRESSES NORMAL HUMAN BRONCHIAL EPITHELIAL CELLS TO FULL MALIGNANCY "2012
Author(s)
Sato M, Larsen J, Lee W, Shames D, Ignacio I. Gazdar W, Shay J, Minna D, Kondo M, Hasegawa Y.
Organizer
5th APLCC (Asian Pacific Lung Cancer Congress)
Place of Presentation
Fukuoka Japan
Related Report
-
[Presentation] TIMELESS IS OVEREXPRESSED IN LUNG CANCER AND ITS KNOCKDOWN INDUCES APOPTOSIS AND CHEMOSENSITI- ZATION IN LUNG CANCER CELLS2012
Author(s)
Yoshida K, Sato M, Hase T, Momen Elshazley, Yamashita R, Usami N, Taniguchi T, Yokoi K, Kondo M,Girard L, Minna J, Hasegawa Y
Organizer
5th APLCC (Asian Pacific Lung Cancer Congress)
Place of Presentation
Fukuoka Japan
Related Report
-
[Presentation] Transient but not stable ZEB1 knockdown dramatically inhibits growth of malignant pleural mesothelioma cells2011
Author(s)
Horio M, Sato M, Takeyama Y, Elshazley M, Yamashita R, Hase T, Yoshida K, Usami N, Yokoi K, Sekido Y, Kondo M, Toyokuni S, Gazdar AF, Minna JD, Hasegawa Y
Organizer
第14回世界肺癌学会
Place of Presentation
オランダ、アムステルダム
Year and Date
2011-07-04
Related Report
-
[Presentation] Transient but Not Stable ZEB1 Knockdown Dramatically Inhibits Growth of Malignant Pleural Mesothelioma Cells: Implication of EpCAM Up-regulation Induced by ZEB1 Knockdown2011
Author(s)
M. Horio, M. Sato, Y. Takeyama, T. Hase, E. Momen, K. Yoshida, Y. Sekido, M. Kondo, A.F. Gazdar, J.D. Minna, Y. Hasegawa
Organizer
第14回世界肺がん学会
Place of Presentation
オランダ、アムステルダム
Related Report
-
-